S

Seaport Therapeutics

Develops orally bioavailable antidepressants and anxiolytics

Executive Director/Vice President - Clinical Development

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$297k - $370k

About the Job

Requirements

  • MD training in psychiatry and/or neuroscience is required.
  • At least 8 years of clinical development experience at the Executive Director level or 10 years at the Vice President level in a biotech or pharmaceutical setting, with a strong track record of successful clinical program execution in neuropsychiatric drug development.
  • Prior clinical or academic experience is required.
  • Experience with Good Clinical Practice, International Council for Harmonisation requirements, Food and Drug Administration requirements, clinical trial design and strategies, interpretation of clinical data, and generation of supporting regulatory submissions of clinical study documents.
  • Experience working cross-functionally across research and development functions and beyond.
  • Experience with Phase I–III clinical development is required.
  • Understanding of the healthcare environment in the United States and elsewhere, including laws, regulations, and evolving market access trends and issues.
  • Knowledge and experience building clinical development infrastructure aligned with the needs of a growing organization.
  • Occasional work travel is required as needed.

Responsibilities

  • Establish and drive clinical development strategy and hands-on tactical execution plans for programs across the current and future development portfolio.
  • Manage internal and external relationships, including with executive leadership, regulatory affairs, clinical operations, medical affairs, regulatory agencies, partners, key opinion leaders, and investigators.
  • Provide medical oversight of ongoing clinical trials in the neuropsychiatric therapeutic area.
  • Lead clinical sections of regulatory documents, including Investigational New Drug and Biologics License Application/New Drug Application submissions.
  • Work with Regulatory Affairs to prepare for meetings with the Food and Drug Administration and other healthcare authorities.
  • Work with Scientific Communications and Medical Affairs team members to organize and prepare for advisory board meetings.
  • Work with program team members through all phases of development through commercialization.
  • Prioritize and develop current drug candidates and future pipeline compounds, and contribute to go/no-go decisions.
  • Conduct literature reviews, interact with key opinion leaders, attend scientific meetings, and present the clinical development plan to relevant internal stakeholders to help shape new indication selection.
  • Ensure Clinical Development standard operating procedures facilitate effective clinical research protocols and comply with clinical, medical, and industry standards.
  • Participate in strategic planning for the clinical development organization and support business development and licensing activities.
  • Maintain an understanding of competitors and clinical developments in relevant therapeutic areas.
  • Build and maintain medical advisory boards through working relationships with key opinion leaders and lead clinical investigators.

Desired Qualifications

  • Experience with mood and anxiety disorders is preferred.
  • Experience with successful New Drug Application submissions and approvals and interactions with regulatory agencies is highly desired.

About the Company

Seaport Therapeutics

Develops orally bioavailable antidepressants and anxiolytics

Seaport Therapeutics develops new antidepressants and anxiolytics for neuropsychiatric disorders. Its products are designed to be orally bioavailable and to avoid first-pass metabolism while minimizing hepatotoxicity and other side effects. The company advances drug candidates through clinical trials and regulatory approval with the aim of commercialization, either directly or via partnerships and licensing with larger pharmaceutical companies. The team combines biotech industry experience to support development and execution. Unlike some peers, Seaport focuses on PK properties that improve oral bioavailability and safety, aiming for drugs that patients can take easily and with fewer liver-related risks. The overarching goal is to bring safe, effective neuropsychiatric medications to patients by progressing through development to market, leveraging partnerships to scale.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Seaport Therapeutics

See more jobs